Case Report: Transverse myelitis following CAR-T cell therapy for post-transplant lymphoproliferative disorder
We report a case of severe, irreversible transverse myelitis following CD19-directed CAR-T cell therapy (axicabtagene ciloleucel) for refractory post-transplant lymphoproliferative disorder (PTLD) in a young female lung-transplant recipient. This case …